Christopher Richard Anzalone
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $24.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 7,4163,798,510 held (−0%) | $65.88 | $489K | -4.8% |
| Jan 5SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 5,7713,792,739 held (−0%) | $66.39 | $383K | -5.5% |
| Dec 30SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 35,1813,822,471 held (−1%) | $69.33 | $2.4M | -9.5% |
| Dec 30SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 16,5453,805,926 held (−0%) | $68.69 | $1.1M | -8.6% |
| Dec 23SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 3,9793,827,978 held (−0%) | $66.67 | $265K | -5.9% |
| Dec 23SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 8,1473,819,831 held (−0%) | $68.01 | $554K | -7.7% |
| Dec 23SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 1,3193,818,512 held (−0%) | $68.48 | $90K | -8.4% |
| Dec 23SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 10,0123,808,500 held (−0%) | $68.33 | $684K | -8.2% |
| Dec 23SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell Plan | 2,5743,805,926 held (−0%) | $68.85 | $177K | -8.9% |
| Dec 19SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 46,2873,870,670 held (−1%) | $63.55 | $2.9M | -1.3% |
| Dec 19SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 35,7503,834,920 held (−1%) | $64.51 | $2.3M | -2.7% |
| Dec 19SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 9823,833,938 held (−0%) | $65.53 | $64K | -4.2% |
| Dec 19SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 1,9813,831,957 held (−0%) | $66.30 | $131K | -5.4% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 100,5324,000,723 held (−2%) | $68.67 | $6.9M | -8.6% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 21,3213,979,402 held (−1%) | $69.28 | $1.5M | -9.4% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 8,1473,971,255 held (−0%) | $69.96 | $570K | -10.3% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 8,4163,962,839 held (−0%) | $60.51 | $509K | +3.7% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 10,9633,951,876 held (−0%) | $61.25 | $671K | +2.4% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 14,0953,937,781 held (−0%) | $62.12 | $876K | +1.0% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 8,4763,929,305 held (−0%) | $62.94 | $533K | -0.3% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 6,6613,922,644 held (−0%) | $64.29 | $428K | -2.4% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 1,0003,921,644 held (−0%) | $64.96 | $65K | -3.4% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 1,3003,920,344 held (−0%) | $65.77 | $86K | -4.6% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 1663,920,178 held (−0%) | $66.77 | $11K | -6.0% |
| Dec 16SEC | ARWRArrowhead Pharmaceuticals, Inc. | Sell | 3,2213,916,957 held (−0%) | $67.87 | $219K | -7.5% |
- Sell
CEO Christopher Richard Anzalone sold $489K of ARWR at $65.88 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Richard Anzalone sold $383K of ARWR at $66.39 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Richard Anzalone sold $2.4M of ARWR at $69.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Richard Anzalone sold $1.1M of ARWR at $68.69 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Richard Anzalone sold $265K of ARWR at $66.67 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Richard Anzalone sold $554K of ARWR at $68.01 — pre-scheduled 10b5-1 plan sale.